{"id":94661,"date":"2023-09-21T10:30:00","date_gmt":"2023-09-21T08:30:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=94661"},"modified":"2023-09-21T10:00:20","modified_gmt":"2023-09-21T08:00:20","slug":"adivo-becomes-part-of-zoetis","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/94661\/adivo-becomes-part-of-zoetis\/","title":{"rendered":"Adivo becomes part of Zoetis"},"content":{"rendered":"<div class=\"entry-content\">\n<p>Adivo and Zoetis have been collaborating on antibody research for dogs and cats since 2021. In addition to research collaborations, Adivo has developed its own portfolio of antibody drug candidates in oncology and inflammatory diseases, with a first patient trial for the treatment of solid tumors in dogs initiated in early 2023. <\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;We founded Adivo with the vision of bringing the benefits of next-generation monoclonal antibody therapeutics to pet owners and their beloved companions worldwide. By joining forces with Zoetis, we have multiple approaches to deliver more gold-standard, species-specific therapeutic antibodies to companion animals,&quot; <\/p><\/blockquote>\n\n\n\n<p>says<strong> Kathrin Ladetzki-Baehs, <\/strong>Founder and CEO of Adivo. <\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;I am very proud of the Adivo team&#039;s achievements after just five years of operations and minimal seed funding to begin our journey. I look forward to seeing what our team can achieve as part of a leading organization with global reach while continuing to grow in one of Europe&#039;s leading biopharmaceutical centers.&quot;<\/p><\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\">Innovation Center in Puchheim<\/h2>\n\n\n\n<p><strong>Rob Polzer, <\/strong>Executive Vice President and President of Research and Development of <a href=\"https:\/\/www2.zoetis.de\/\" target=\"_blank\" rel=\"noreferrer noopener\">Zoetis<\/a>, says about the takeover:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;As a global leader in animal health, we are constantly seeking new business development opportunities and external innovation activities that can complement our internal research and development capabilities. The addition of Adivo to our R&amp;D organization brings unique platforms that can accelerate our research and portfolio, potentially helping us address our customers&#039; unmet needs in oncology, inflammatory diseases, and other areas. We look forward to the opportunities ahead.&quot;<\/p><\/blockquote>\n\n\n\n<p>With more than 1,000 m\u00b2 of laboratory space in Puchheim near Munich, Adivo will serve as one of Zoetis&#039; innovation centers for antibody drug research.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">\u201cGreat development in recent years\u201d<\/h2>\n\n\n\n<p>In 2018, Kathrin Ladetzki-Baehs and Markus Waldhuber, the two founders of Adivo, secured a <a href=\"\/en\/39465\/adivo-seed-financing\/\">Seed financing<\/a>, in which HTGF, Occident and MorphoSys AG participated. According to the <a href=\"https:\/\/insights.munich-startup.de\/companies\/adivo_1\">Munich Startup Insights<\/a> To date, the company has raised a total of 2.5 million euros.  <\/p>\n\n\n\n<p><strong>Angelika Vlachou<\/strong>, partner at HTGF, comments: <\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>&quot;We are delighted that Adivo, with its outstanding and powerful technology, has been acquired by Zoetis. As one of Adivo&#039;s first investors, it has been impressive to witness its tremendous development over the past few years. The acquisition by Zoetis is now the next logical step in bringing next-generation antibody therapeutics closer to use in animal patients.&quot;<\/p><\/blockquote>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>The Munich-based biotech company Adivo, which focuses on the development of species-specific therapeutic antibodies for companion animals, is becoming part of Zoetis, a US manufacturer of veterinary medicines and vaccines for companion animals and farm animals. Previous investors High-Tech Gr\u00fcnderfonds (HTGF), Occident, and Morphosys AG have sold their shares as part of the transaction. <\/p>","protected":false},"author":24,"featured_media":39532,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1],"tags":[3291,223],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Adivo wird Teil von Zoetis - Munich Startup<\/title>\n<meta name=\"description\" content=\"Das M\u00fcnchner Biotech-Unternehmen Adivo wird Teil von Zoetis, einem Hersteller von Tierarzneimitteln und Impfstoffen f\u00fcr Haus- und Nutztiere.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/94661\/adivo-becomes-part-of-zoetis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adivo wird Teil von Zoetis - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Das M\u00fcnchner Biotech-Unternehmen Adivo wird Teil von Zoetis, einem Hersteller von Tierarzneimitteln und Impfstoffen f\u00fcr Haus- und Nutztiere.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/94661\/adivo-becomes-part-of-zoetis\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-21T08:30:00+00:00\" \/>\n<meta name=\"author\" content=\"Regina Bruckschl\u00f6gl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Regina Bruckschl\u00f6gl\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/94661\/adivo-wird-teil-von-zoetis\/\",\"url\":\"https:\/\/cms.munich-startup.net\/94661\/adivo-wird-teil-von-zoetis\/\",\"name\":\"Adivo wird Teil von Zoetis - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/94661\/adivo-wird-teil-von-zoetis\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/94661\/adivo-wird-teil-von-zoetis\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/08\/Foto-adivo-e1535013000392.jpg\",\"datePublished\":\"2023-09-21T08:30:00+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f\"},\"description\":\"Das M\u00fcnchner Biotech-Unternehmen Adivo wird Teil von Zoetis, einem Hersteller von Tierarzneimitteln und Impfstoffen f\u00fcr Haus- und Nutztiere.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/94661\/adivo-wird-teil-von-zoetis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/94661\/adivo-wird-teil-von-zoetis\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/94661\/adivo-wird-teil-von-zoetis\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/08\/Foto-adivo-e1535013000392.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/08\/Foto-adivo-e1535013000392.jpg\",\"width\":957,\"height\":427,\"caption\":\"Adivo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/94661\/adivo-wird-teil-von-zoetis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Adivo wird Teil von Zoetis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f\",\"name\":\"Regina Bruckschl\u00f6gl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g\",\"caption\":\"Regina Bruckschl\u00f6gl\"},\"description\":\"Nach eigenen Startup-Erfahrungen blickt sie als Redakteurin von Munich Startup nun aus einer anderen Perspektive auf die M\u00fcnchner Startup-Szene \u2013 und entdeckt dabei jeden Tag, wie vielf\u00e4ltig das M\u00fcnchner \u00d6kosystem ist. Startup Stories, die erz\u00e4hlt werden wollen!\",\"sameAs\":[\"https:\/\/cms.munich-startup.net\"],\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/regina\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2018\/08\/Foto-adivo-e1535013000392.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"957\" \/>\n\t<meta property=\"og:image:height\" content=\"427\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adivo becomes part of Zoetis - Munich Startup","description":"The Munich-based biotech company Adivo is becoming part of Zoetis, a manufacturer of veterinary medicines and vaccines for companion animals and farm animals.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/94661\/adivo-becomes-part-of-zoetis\/","og_locale":"en_US","og_type":"article","og_title":"Adivo wird Teil von Zoetis - Munich Startup","og_description":"Das M\u00fcnchner Biotech-Unternehmen Adivo wird Teil von Zoetis, einem Hersteller von Tierarzneimitteln und Impfstoffen f\u00fcr Haus- und Nutztiere.","og_url":"https:\/\/cms.munich-startup.net\/en\/94661\/adivo-becomes-part-of-zoetis\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2023-09-21T08:30:00+00:00","author":"Regina Bruckschl\u00f6gl","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Regina Bruckschl\u00f6gl","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/94661\/adivo-wird-teil-von-zoetis\/","url":"https:\/\/cms.munich-startup.net\/94661\/adivo-wird-teil-von-zoetis\/","name":"Adivo becomes part of Zoetis - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/94661\/adivo-wird-teil-von-zoetis\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/94661\/adivo-wird-teil-von-zoetis\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/08\/Foto-adivo-e1535013000392.jpg","datePublished":"2023-09-21T08:30:00+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f"},"description":"The Munich-based biotech company Adivo is becoming part of Zoetis, a manufacturer of veterinary medicines and vaccines for companion animals and farm animals.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/94661\/adivo-wird-teil-von-zoetis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/94661\/adivo-wird-teil-von-zoetis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/94661\/adivo-wird-teil-von-zoetis\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/08\/Foto-adivo-e1535013000392.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/08\/Foto-adivo-e1535013000392.jpg","width":957,"height":427,"caption":"Adivo"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/94661\/adivo-wird-teil-von-zoetis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Adivo wird Teil von Zoetis"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/4733256eff8ed883081bf4d616fa784f","name":"Regina Bruckschl\u00f6gl","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b783cd1e1497db1e22684a06f3369381?s=96&d=blank&r=g","caption":"Regina Bruckschl\u00f6gl"},"description":"After her own startup experiences, she now looks at the Munich startup scene from a different perspective as an editor at Munich Startup \u2013 and discovers every day how diverse the Munich ecosystem is. Startup stories that beg to be told!","sameAs":["https:\/\/cms.munich-startup.net"],"url":"https:\/\/cms.munich-startup.net\/en\/author\/regina\/"}]},"og_image":[{"width":957,"height":427,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2018\/08\/Foto-adivo-e1535013000392.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1695283280:24","_edit_last":"24","_yoast_wpseo_focuskw":"Adivo","_yoast_wpseo_metadesc":"Das M\u00fcnchner Biotech-Unternehmen Adivo wird Teil von Zoetis, einem Hersteller von Tierarzneimitteln und Impfstoffen f\u00fcr Haus- und Nutztiere.","_yoast_wpseo_linkdex":"71","_thumbnail_id":"39532","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"30","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"0","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"2","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/94661"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=94661"}],"version-history":[{"count":4,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/94661\/revisions"}],"predecessor-version":[{"id":94667,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/94661\/revisions\/94667"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/39532"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=94661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=94661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=94661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}